New K+-sensitive dual-mode imaging probe for diagnosis of tumor malignancy

NewsGuard 100/100 Score

Tumor malignancy identification plays an essential role in clinical management of cancer. Currently, biopsy is the gold standard for malignancy identification in most tumor cases, it is, however, invasive that can cause great discomfort to patients, and potentially increase the risk of distant metastases due to the complex sampling process. With the development of molecular imaging probes, non-invasive medical imaging approaches, such as magnetic resonance imaging (MRI), fluorescence imaging (FI), computed tomography, and ultrasound, etc., have been used for non-invasive tumor diagnosis. Nevertheless, majority of imaging strategies are often dependent on imaging probes that lack specificity for identification of tumor malignancy.

Considering that necrotic cell death and overexpressed potassium ions (K+) channels are major hallmarks of malignant tumors, but not for benign ones, the extracellular K+ concentration is significantly elevated in the malignant tumor microenvironment compared with that of benign tissue. Based on this, a new research led by Prof. Daishun Ling from Shanghai Jiao Tong University reported a K+-sensitive dual-mode imaging probe (KDMN) to realize real-time tumor imaging while identifying the malignancy.

The KDMN consists of optical K+ indicators embedded in magnetic mesoporous silica nanoparticle, which is subsequently coated with a K+-selective membrane that exclusively permits the passage of K+ while excluding other cations. The KDMNs afford superior MR contrast effect and K+-specific FI performance. Moreover, KDMN-enhanced MRI confers attenuated signals at the tumor sites for effective tumor detection. Meanwhile, KDMN-based K+-sensitive FI provides a significant difference in fluorescence signals between malignant tumors and benign ones because there is an elevated extracellular K+ concentration in the malignant tumor microenvironment. Notably, the integration of KDMN-based MRI and FI via cascaded logic circuit has successfully achieved self-confirmation of dual-mode imaging results, thus allowing reliable and accurate imaging of tumor malignancy.

The study was recently published in National Science Review. The first author is Dr. Qiyue Wang, and the corresponding authors are Prof. Daishun Ling from Shanghai Jiao Tong University and Prof. Fangyuan Li from Zhejiang University.

This is the first demonstration of a K+-sensitive dual-mode imaging probe for MRI/FI-cross-checked diagnosis of tumor malignancy. And this ion-sensitive cascaded 'AND' logic imaging strategy would pave the way for the development of next-generation imaging probes for highly sensitive and accurate diagnosis of ion dyshomeostasis associated diseases."

Prof. Daishun Ling from Shanghai Jiao Tong University

Source:
Journal reference:

Wang, Q., et al. (2022) A K+-sensitive AND-gate dual-mode probe for simultaneous tumor imaging and malignancy identification. National Science Review. doi.org/10.1093/nsr/nwac080.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify increased brain tumor risk with specific contraceptive use